Oxygen Biotherapeutics takes a break, OXiGENE goes parabolic

|By:, SA News Editor

Shares of Oxygen Biotherapeutics (OXBT -5%) are taking a breather today (perhaps we should call it a well-deserved rest) after running up over 300% in five sessions.

Incidentally, MarketWatch has picked up on the recent rally, noting that OXBT "could have been considered a penny stock [last week] with shares trading under $2" before the levosimendan news helped the stock "more than quintuple."

Meanwhile, shares of similarly-named OXiGENE (OXGN +74.4%) are staging a fantastic rally, on volume of 9.2M versus a 10-day average of just 55K. Here's SA contributor PropThink: "Now we're just walking backwards through the NASDAQ listings."